These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Does severe ADAMTS13 deficiency in thrombotic microangiopathy rule out complement-mediated atypical hemolytic uremic syndrome. Arumugam V; Bhowmick R; Agarwal I; Arumadi M Saudi J Kidney Dis Transpl; 2019; 30(3):701-705. PubMed ID: 31249236 [TBL] [Abstract][Full Text] [Related]
7. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. Tsai HM J Am Soc Nephrol; 2003 Apr; 14(4):1072-81. PubMed ID: 12660343 [TBL] [Abstract][Full Text] [Related]
8. The role of von Willebrand factor in thrombotic microangiopathy. Noone DG; Riedl M; Licht C Pediatr Nephrol; 2018 Aug; 33(8):1297-1307. PubMed ID: 28748411 [TBL] [Abstract][Full Text] [Related]
9. Treatment of Congenital Thrombotic Thrombocytopenic Purpura With Eculizumab. Pecoraro C; Ferretti AV; Rurali E; Galbusera M; Noris M; Remuzzi G Am J Kidney Dis; 2015 Dec; 66(6):1067-70. PubMed ID: 26409664 [TBL] [Abstract][Full Text] [Related]
11. The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies. Phillips EH; Westwood JP; Brocklebank V; Wong EK; Tellez JO; Marchbank KJ; McGuckin S; Gale DP; Connolly J; Goodship TH; Kavanagh D; Scully MA J Thromb Haemost; 2016 Jan; 14(1):175-85. PubMed ID: 26559391 [TBL] [Abstract][Full Text] [Related]
12. A novel homozygous missense ADAMTS13 mutation Y658C in a patient with recurrent thrombotic thrombocytopenic purpura. Lee SH; Park JH; Park SK; Lee EH; Choi JI; Visentin GP; Park TS; Oh SH; Kim SR Ann Clin Lab Sci; 2011; 41(3):273-6. PubMed ID: 22075512 [TBL] [Abstract][Full Text] [Related]
13. Thrombotic microangiopathy: focus on atypical hemolytic uremic syndrome. Sperati CJ; Moliterno AR Hematol Oncol Clin North Am; 2015 Jun; 29(3):541-59. PubMed ID: 26043391 [TBL] [Abstract][Full Text] [Related]
17. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245 [TBL] [Abstract][Full Text] [Related]
18. A mechanistic approach to the diagnosis and management of atypical hemolytic uremic syndrome. Tsai HM Transfus Med Rev; 2014 Oct; 28(4):187-97. PubMed ID: 25280590 [TBL] [Abstract][Full Text] [Related]
19. Single-nucleotide variations defining previously unreported ADAMTS13 haplotypes are associated with differential expression and activity of the VWF-cleaving protease in a Salvadoran congenital thrombotic thrombocytopenic purpura family. Kim B; Hing ZA; Wu A; Schiller T; Struble EB; Liuwantara D; Kempert PH; Broxham EJ; Edwards NC; Marder VJ; Simhadri VL; Sauna ZE; Howard TE; Kimchi-Sarfaty C Br J Haematol; 2014 Apr; 165(1):154-8. PubMed ID: 24433405 [No Abstract] [Full Text] [Related]
20. Complement activation in diseases presenting with thrombotic microangiopathy. Meri S Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]